Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy by Wei-Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short

Get full text

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusiv... by Maymona G. Abdelmagid, Aref Al-Kali, Mark R. Litzow, Kebede H. Begna, William J. Hogan, Mirinal S. Patnaik, Shahrukh K. Hashmi, Michelle A. Elliott, Hassan Alkhateeb, Omer S. Karrar, Farah Fleti, Mohammed H. Elnayir, Candido E. Rivera, Hemant S. Murthy, James M. Foran, Mohamed A. Kharfan-Dabaja, Talha Badar, David S. Viswanatha, Kaaren K. Reichard, Naseema Gangat, Ayalew Tefferi

Get full text